These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 24805954

  • 1. Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation?
    de Beus E, de Jager R, Joles JA, Grassi G, Blankestijn PJ.
    J Hypertens; 2014 Sep; 32(9):1751-61. PubMed ID: 24805954
    [Abstract] [Full Text] [Related]

  • 2. Sustained Decrease in Blood Pressure and Reduced Anatomical and Functional Reinnervation of Renal Nerves in Hypertensive Sheep 30 Months After Catheter-Based Renal Denervation.
    Singh RR, McArdle ZM, Iudica M, Easton LK, Booth LC, May CN, Parkington HC, Lombardo P, Head GA, Lambert G, Moritz KM, Schlaich MP, Denton KM.
    Hypertension; 2019 Mar; 73(3):718-727. PubMed ID: 30661475
    [Abstract] [Full Text] [Related]

  • 3. Pathophysiology I: the kidney and the sympathetic nervous system.
    de Jager RL, Blankestijn PJ.
    EuroIntervention; 2013 May; 9 Suppl R():R42-7. PubMed ID: 23732154
    [Abstract] [Full Text] [Related]

  • 4. Renal denervation decreases susceptibility of the heart to ventricular fibrillation in a canine model of chronic kidney disease.
    Tang X, Shi L, Cui X, Yu Y, Qi T, Chen C, Tang X.
    Exp Physiol; 2017 Nov 01; 102(11):1414-1423. PubMed ID: 28833735
    [Abstract] [Full Text] [Related]

  • 5. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
    Hering D, Esler MD, Schlaich MP.
    EuroIntervention; 2013 May 01; 9 Suppl R():R127-35. PubMed ID: 23732145
    [Abstract] [Full Text] [Related]

  • 6. Renal nerve ablation for hypertensive patients with chronic kidney disease.
    Papademetriou V, Doumas M, Anyfanti P, Faselis C, Kokkinos P, Tsioufis C.
    Curr Vasc Pharmacol; 2014 Jan 01; 12(1):47-54. PubMed ID: 23905594
    [Abstract] [Full Text] [Related]

  • 7. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension.
    Schlaich MP.
    Am J Hypertens; 2017 Sep 01; 30(9):847-856. PubMed ID: 28338871
    [Abstract] [Full Text] [Related]

  • 8. Renal denervation enhances GABA-ergic input into the PVN leading to blood pressure lowering in chronic kidney disease.
    Nishihara M, Takesue K, Hirooka Y.
    Auton Neurosci; 2017 May 01; 204():88-97. PubMed ID: 27729205
    [Abstract] [Full Text] [Related]

  • 9. Renal sympathetic denervation and renal physiology.
    Kalaitzidis RG, Karasavvidou D, Siamopoulos KC.
    Curr Clin Pharmacol; 2013 Aug 01; 8(3):189-96. PubMed ID: 23173964
    [Abstract] [Full Text] [Related]

  • 10. Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease.
    Nishihara M, Takesue K, Hirooka Y.
    Clin Exp Hypertens; 2019 Aug 01; 41(3):211-219. PubMed ID: 29694249
    [Abstract] [Full Text] [Related]

  • 11. Procedural Reassessment of Radiofrequency Renal Denervation in Resistant Hypertensive Patients.
    Rabbia F, Testa E, Fulcheri C, Berra E, Di Monaco S, Covella M, Pappaccogli M, Monticone S, Rosiello R, Rossato D, Veglio F.
    High Blood Press Cardiovasc Prev; 2017 Jun 01; 24(2):187-192. PubMed ID: 28374154
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Toennes SW, Ewen S, Ditting T, Veelken R, Ukena C, Uder M, Böhm M, Schmieder RE.
    J Hypertens; 2015 Jun 01; 33(6):1261-6. PubMed ID: 25923731
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathophysiology of resistant hypertension in chronic kidney disease.
    Campese VM.
    Semin Nephrol; 2014 Jun 01; 34(5):571-6. PubMed ID: 25416666
    [Abstract] [Full Text] [Related]

  • 16. Sympathetic hyperactivity in chronic kidney disease: pathophysiology and (new) treatment options.
    Vink EE, de Jager RL, Blankestijn PJ.
    Curr Hypertens Rep; 2013 Apr 01; 15(2):95-101. PubMed ID: 23354877
    [Abstract] [Full Text] [Related]

  • 17. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M.
    Clin Res Cardiol; 2016 Apr 01; 105(4):364-71. PubMed ID: 26493305
    [Abstract] [Full Text] [Related]

  • 18. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP.
    Hypertension; 2014 Jul 01; 64(1):118-24. PubMed ID: 24732891
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.